Lilly rises on CVS Zepbound addition
Eli Lilly stock gains after CVS adds Zepbound to its drug list, potentially increasing demand. This move may boost Lilly's sales.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.